Rapid Diagnostics

Delhi, India Founded: 1995 • Age: 31 yrs Minicorn
IVD analyzers, POC devices, and critical care equipment are manufactured.

About Rapid Diagnostics

Rapid Diagnostics is a company based in Delhi (India) founded in 1995 by Bharat Jindal. Rapid Diagnostics has raised $2.91 million across 4 funding rounds from investors including Deep Laboratories, Onkarlaboratories and Karwa Enterprise. The company has 94 employees. Rapid Diagnostics offers products and services including In-Vitro Diagnostics, Critical Care Monitoring, and Personal Healthcare.

Operational Areas
Key Metrics
  • Annual Revenue
    ₹105 Cr

    FY 2025 · +15% YoY

  • Net Profit
    ₹7.94 Cr

    FY 2025 · 8% margin

  • EBITDA
    ₹13.45 Cr

    FY 2025 · 13% margin

  • Total Equity Funding
    $2.91M (USD)

    in 4 rounds

  • Latest Funding Round
    $1.18M (USD), Unspecified

    Mar 2014

  • Employee Count
    94

Products & Services of Rapid Diagnostics

Rapid Diagnostics offers a comprehensive portfolio of products and services, including In-Vitro Diagnostics, Critical Care Monitoring, and Personal Healthcare.

In-Vitro Diagnostics
Diagnostic Instruments

Provides accurate tests for medical diagnostics and reliable results.

Critical Care Monitoring
Life Support Systems

Offers advanced monitoring for critical patient care and support.

Personal Healthcare
Health Solutions

Delivers comprehensive products for individual health and well-being.

Funding Insights of Rapid Diagnostics

Rapid Diagnostics has successfully raised a total of $2.91M across 4 strategic funding rounds. The most recent funding activity was a Unspecified round of $1.18 million completed in March 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $2.91M
  • Total Rounds 4
  • Last Round Unspecified β€” $1.18M
  • First Round $318,069

    (Jan 2007)

  • Investors Count 7

All 4 funding rounds of Rapid Diagnostics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Mar 2014$1.18MUnspecified$5.24MDeep Laboratories
–
Mar 2012$1.03MUnspecified$16.41MOnkarlaboratories
Mar 2011$378,017Unspecified$β€’β€’β€’β€’β€’Aspen Laboratories
–
Jan 2007$318,069Unspecified$β€’β€’β€’β€’β€’Jagat Diagnostic
Valuation history
DateValuationStage
Mar 2014$5.24Mβ€’β€’β€’β€’β€’β€’β€’β€’
Mar 2012$16.41Mβ€’β€’β€’β€’β€’β€’β€’β€’
Mar 2011$β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’
Jan 2007$β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’
Premium access

Full valuation and stage history of Rapid Diagnostics

Every valuation point, the growth-stage changes (minicorn, soonicorn, unicorn) and the dates behind them require an active premium plan.

  • All valuation points
  • Stage changes
  • Dates
  • Exports

Verified entity values are shown only after access is granted.

Last known valuation $5.24M (Mar 2014). 7 investors in total: 6 institutional and 1 angel.

Investors in Rapid Diagnostics

Rapid Diagnostics has secured backing from 7 investors, including institutional and angel investors. Prominent investors backing the company include Deep Laboratories, Onkarlaboratories and Karwa Enterprise.

All
Institutional
Angel
InvestorDescriptionFounded YearDomainLocation
-
–deeplaboratories.tcc.mode-
-
–onkarlaboratories.tcc.mode-
-
–karwaenterprise.tcc.mode-
-
–aspenlaboratories.tcc.mode-
-
–jagatdiagnostic.tcc.mode-
-
–deepmeditech.tcc.mode-

Bharat Jindal

-
–unknown_cb7f1e665a914adb9-
Premium access

Investor details for Rapid Diagnostics

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Rapid Diagnostic Private Limited (Rapid Diagnostics)

Rapid Diagnostic Private Limited is the primary company behind Rapid Diagnostics. The boards of the 2 registered companies of Rapid Diagnostics currently have 2 directors; the longest-serving is Bharat Bhushan Jindal, appointed in 1995. 1 earlier director has ceased.

DirectorDesignationAppointedTenureEntity
Bharat Bhushan Jindal
DIN 00271318
Director21 Aug 199531 yrs 1 moAspen Diagnostics Private Limited, Rapid Diagnostic Private Limited
Lalita Jindal
DIN 00271356
Director21 Aug 199531 yrs 1 moAspen Diagnostics Private Limited, Rapid Diagnostic Private Limited

People of Rapid Diagnostics

1 people are tracked at Rapid Diagnostics (1 in leadership); the tracked headcount is 94.

NameRoleGroup
FounderLeadership
Premium access

Complete people profiles for Rapid Diagnostics

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of Rapid Diagnostics

Figures of Rapid Diagnostic Private Limited, the primary company behind Rapid Diagnostics, for FY 2025. Revenue was ₹105 Cr (+15% year on year). Net profit was ₹7.94 Cr (8% margin). EBITDA was ₹13.45 Cr (13% margin). Revenue has grown at a compounded annual rate of -3% over three years and 0% over five years.

  • ₹105 CrRevenue · FY 2025 · +15% YoY
  • ₹7.94 CrNet profit · 8% margin
  • ₹13.45 CrEBITDA · 13% margin
  • ₹1.08 CrPaid-up capital
  • 94Employees (provident fund records)
  • -3%Revenue CAGR, 3 years
  • 0%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Rapid Diagnostic Private Limited are on its company page.

Premium access

Detailed financial statements for Rapid Diagnostics

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of Rapid Diagnostics

4 dated milestones of Rapid Diagnostics across 19 years, from founding to its latest funding, stage changes and deals.

  1. Founded Rapid Diagnostics is founded.
  2. Funding First funding round of $318K.
  3. Milestone Reaches Minicorn status.
  4. Funding Latest funding round, Unspecified, of $1.2M.

Web traffic of Rapid Diagnostics

Websites that share an audience with Rapid Diagnostics (rapiddiagnostic.in).

Similar websites

Websites whose visitors overlap most with Rapid Diagnostics. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
medicards.in
medicards.in
100%
–––
vijayadiagnostic.com
100%
610.2K#91,683View details
bhatbiotech.com
61%
1.9K#8,619,767View details

Similar companies to Rapid Diagnostics

10 companies that operate in the same segment as Rapid Diagnostics (Diagnostics & Lab Tech), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Pharmaceuticals and diagnostics kits are developed for various diseases.
1896Basel, Basel-stadt, Switzerland–USD 77.61 B103,250
Point-of-care and laboratory blood analyzers are developed by EKF.
1990Penarth, Wales, United KingdomUSD 178.63 KUSD 69.43 M303
Blood testing services are offered using finger-prick microsamples.
2017Austin, Texas, United StatesUSD 37.7 M––
Manufactures clinical diagnostic test kits
1971Irvine, California, United States–USD 4.45 M54
Biomarker-based diagnostic solutions for cancer and cardiovascular diseases are developed.
2002Hennigsdorf, Brandenburg, GermanyUSD 36.14 M––
Diagnostic instrumentation and assays
1987Puteaux, Hauts-de-seine, France–––
Manufacturer of Laboratory equipment
1955Norwood, Massachusetts, United States–––
Cloud based diagnostics platform for point of care diagnosing
2014Waltham, Massachusetts, United StatesUSD 703.91 MUSD 115.02 K9
Diagnostics technology for infectious diseases and health monitoring is provided.
2012Hong Kong, ChinaUSD 34 M––
Global leader for In Vitro Diagnostic
1959Barcelona, Catalonia, Spain–USD 61.01 M346
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Rapid Diagnostics

Rapid Diagnostics was founded in 1995 and raised its 1st funding round 12 years after it was founded.

Rapid Diagnostics is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.

Rapid Diagnostics is a funded company, having raised a total of $2.91M across 4 funding rounds to date. The company's 1st funding round was a Unspecified of $318.07K, raised on Jan 2007.

Rapid Diagnostics has 94 employees.

The primary company behind Rapid Diagnostics, Rapid Diagnostic Private Limited, reported revenue of β‚Ή105 Cr for FY 2025, up 15% year on year.

Rapid Diagnostics is an Indian group of companies engaged in the development and manufacture of a wide range of IVD analyzers, POC diagnostic devices and monitoring equipment for critical care. The companys portfolio includes analyzers for biochemical assays, haematology, coagulation assays, urinalysis, electrolyte analysis, HbA1c analyzers, rapid tests, POC glucometers, POC and hand-held haemoglobinometers, BP instruments, and related consumables and kits. In their critical care portfolio are included multi-parameter patient monitoring systems, EGC machines, fetal Doppler monitors, pulse oximeters, defibrillators, ventilators, oxygen concentrators, and sleep apnoea therapy devices.

Rapid Diagnostics offers In-Vitro Diagnostics, Critical Care Monitoring, and Personal Healthcare.

Rapid Diagnostics has 7 investors. Key investors include Deep Laboratories, Onkarlaboratories, Karwa Enterprise, Aspen Laboratories, and Jagat Diagnostic.

The valuation of Rapid Diagnostics is $5.24M as of Mar 2014.

Rapid Diagnostics is associated with 2 legal entities: Rapid Diagnostic Private Limited, Aspen Diagnostics Private Limited.

The legal entities of Rapid Diagnostics currently have 2 directors, including Bharat Bhushan Jindal, Lalita Jindal.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available